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11.6
Autologous chondrocyte implantation in patients 45 years and 
older
T. Minas1, A.H. Gomoll2, T. Bryant3, R.E. Rosenberger2;
1Harvard Medical School, Brigham and Women‘s Hospital, Chestnut 
Hill, United States of America, 2Department Of Orthopedic Surgery, 
Harvard Medical School, Boston, MA, United States of America, 
3Department Of Orthopedic Surgery, Harvard Medical School, 
Boston, United States of America
Purpose: ACI has proven to be a successful and durable treatment 
option for full thickness chondral defects of the knee. The purpose of 
the present study was to determine whether increasing patient age 
adversely affects clinical outcome as many patients > 45 years old 
wish to remain active and preserve their joint. 
Methods and Materials: This prospective study reviews patients 
treated > 45 years having ACI involving the weightbearing condyles, 
patella, trochlea in isolation or in combination. The clinical evaluation 
JODMVEFE ¾WF WBMJEBUFE SBUJOH TDBMFT  4IPSU 'PSN .PEJ¾FE
Cincinnati Rating Scale, WOMAC Index, and a Visual Analogue Scale. 
Age, gender, defect size, and additional procedures were recorded. 
5IFDPIPSUXBTUIFOTVCDMBTTJ¾FEJOUP4JNQMF$PNQMFYBOE4BMWBHF
categories. 
Results: The average patient age at index surgery (ACI procedure) 
was 48.7 years [range, 45-60 years]). The minimum follow up was 2 
ZSTUPZSTBWFSBHFPGZFBST5IFSFXFSF¾GUZ¾WFQBUJFOUTXJUI
defects treated with ACI between February 1995 and February 2005. 
The patients’ cohort included 36 males and 19 females. The defects 
were 4.7 cm2/defect, 9.9 cm2 /knee (range, 2.5cm² - 31.6cm²) per 
knee. There were 7 failures of the 55 patients (12.7%). At their latest 
available followup >75% patients would choose ACI as the surgical 
option to treat their symptomatic cartilage defects. 
Conclusions: Our results suggest that ACI is a reliable method in 
treatment of symptomatic full-thickness articular chondral defects 
anywhere in the knee in patients 45 years and older. 
11.7
Friction and wear testing of articular cartilage in a unicondylar 
knee hemiarthroplasty using a pendulum friction simulator
L. McCann1*+6EP¾B2, S. Graindorge2, E. Ingham3, Z. Jin2, J. Fisher2;
1School Of Mechanical Engineering, Institute of Medical and 
Biological Engineering, Leeds, United Kingdom, 2Mechanical
Engineering, University of Leeds, Leeds, United Kingdom, 
3Microbiology, University of Leeds, Leeds, United Kingdom
Purpose: There is growing interest in hemiarthroplasty, biomaterial 
and tissue engineering defect repair for early intervention treatment 
of osteoarthritis in the knee. However, the clinical use of these 
approaches has not been supported by preclinical in vitro testing. 
Previous frictional studies of articular cartilage(AC) have mainly 
focused on simple pin-on-plate geometries. The aim of this study was 
to develop a tribological simulation of the medial compartment of 
the natural knee, to measure the friction and wear of AC against itself 
and against biomaterials suitable for cartilage surface replacement. 
Methods and Materials: Saggital sections from bovine medial 
femoral condyles were articulated against a (a) natural tibial surface 
BOE 	C
 ¿BU - TUBJOMFTT TUFFM DPVOUFSGBDF 	NPEFM GPS B XPSTU
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low and high stress conditions were applied using a pendulum 
simulator(Simsol,UK). Peak loads were varied from 260N-1.5kN 
representing the maximum load in the medial compartment with and 
without the meniscus, respectively. 
Results: Condyles articulating against the cartilage tibial surface 
(for 3600cycles) produced low levels of friction(average m=0.04) 
and no wear was observed under low load conditions. The condyles 
articulating against the metallic counterface (for 3600cycles) showed 
higher friction(average m=0.078), with evidence of AC deformation 
BOEXFBS 4VSGBDF SPVHIOFTT JODSFBTFE TJHOJ¾DBOUMZ GSPNNN
2.7mm. With elevated loading against the metallic counterface the 
wear of the AC was through to the bone and hugely accelerated 
(300cycles). Friction was higher(average m=0.13). 
Conclusions: This model provides a better understanding of AC 
friction and wear in a hemiarthroplasty and particularly highlights 
material and stress as extremely important variables.
11.8
Improvement in symptoms and function after autologous 
chondrocyte implantation (ACI,Carticel) in patients who failed 
prior treatment. Results of the study of treatment of articular 
repair (STAR) trial.
K.R. Zaslav1, B. Cole2, R. Brewster3, T. Berardino4, J. Farr5, P. Fowler6,
C. Nissen7;
1Sports Medicine Center, Advanced Orthopedic Centers, Richmond, 
Virginia, United States of America, 2Orthopaedic Surgery, Rush 
Medical College, Chicago, United States of America, 3Orthopedic
Surgery, Northwest Orthopedic Specialists, Spokane, WA, United 
States of America, 4Orthopedic Surgery, Keller Army Hospital, West 
Point, NY, United States of America, 5Orthoindy, Cartilage Restoration 
Center of Indiana, Indianapolis, United States of America, 6Sports
Medicine, Fowler Kennedy Sports Clinic and London Health Science 
Center, London, OH, Canada, 7Orthopedic Surgery, Connecticut 
Children‘s Medical Center, Hartford, United States of America
Purpose: 5PBTTFTT UIFFG¾DBDZPG"$* JOQBUJFOUTXIPXJUIJO UIF
prior three years, had failed other surgical treatments for cartilage 
defects of the femur. 
Methods and Materials: A prospective multi-center study of ACI 
performed in patients who failed index treatment for articular 
cartilage defects including microfracture, OATS, or debridement. 
Primary endpoint was assessment of survivorship of Carticel and 
non-Carticel treatments. Secondary endpoints included KOOS, 
NPEJ¾FETDBMFTPG$JODJOOBUJ,OFF SBUJOHTZTUFN7"4BOE4'
Serious adverse events including subsequent surgical procedures 
(SSP) were recorded. A sample size of 100 provided 90% power at 
Į=0.05. 
Results: 154 patients received ACI following failure of an index 
treatment. 126 (82%) completed 4-year follow-up. Median age: 
35, median lesion size: 4.0cm². Lesion location: 66% MFC, 17% 
LFC, 17% trochlea, 50 (32%) had multiple lesions. 76% (117/154) 
had improvement at 4 years; the median difference in treatment 
survivorship was 31.68 months. Mean improvements in all outcome 
scores were observed from baseline to all follow-up time points 
(p<0.001). Pre-op to post-op (48 month) values, respectively, are 
KOOS Pain: 48.7 to 72.2; KOOS Sports/Recreation: 25.8 to 55.8; 
,004,OFF2VBMJUZUP,004"%-UPNPEJ¾FE
Cincinnati overall knee condition: 3.26 to 6.31; VAS: 28.8 to 69.9 and 
SF-36 Overall Health: 33 to 44.4. 40% (61/154) had an ACI-related 
4415IFNPTUDPNNPOBSUISPTDPQJD¾OEJOHTXFSFIZQFSUSPQIZBOE
¾CSPTJT
Conclusions: In patients who failed prior cartilage repair procedures 
BOEXIPIBWF MBSHFTZNQUPNBUJDDIPOESBM MFTJPOTXJUITJHOJ¾DBOU
impairment, ACI provided sustained (4 year minimum) clinically 
meaningful improvement. 
